Telbivudine, >=98% (HPLC)

Application

Telbivudine has been used to explore the mechanisms of telbivudine (LdT) induced creatine kinase (CK) elevation.

Biochem/physiol Actions

Telbivudine is a nucleoside analog that is widely used to treat hepatitis B virus (HBV) infection.

Telbivudine is a synthetic molecule containing ?-L-configuration. Telbivudine improves the estimated glomerular filtration rate (eGFR) in response to chronic hepatitis B (CHB). It prevents perinatal transmission and enhances the hepatitis B e antigen (HBeAg) seroconversion. It is also known to cause side effects such as creatine kinase (CK) elevation and fatal rhabdomyolysis.

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Form Assay Price Quantity
3574031 Telbivudine, >=98% (HPLC) white to beige 100 IQFYYKKMVGJFEH-CSMHCCOUSA-N 1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m1/s1 SIGMA-ALDRICH powder ≥98% (HPLC)
£515.36 (exc VAT) per 25MG
-
+
3574032 Telbivudine, >=98% (HPLC) white to beige 100 IQFYYKKMVGJFEH-CSMHCCOUSA-N 1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m1/s1 SIGMA-ALDRICH powder ≥98% (HPLC)
£162.96 (exc VAT) per 5MG
-
+